Antag Therapeutics
PrivateLast Round
Series A
Dec 4, 2024
Total Funding Raised
$87M
Company Overview
Antag Therapeutics is a biopharmaceutical company that develops peptide-based therapies for obesity and cardiometabolic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Antag Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Antag Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 4, 2024 | ||||
| Seed | Apr 1, 2017 |
Key People
Founding team and executive leadership
Antag Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pictet Group | Series A |
| Viva Biotech | Series A |
| Versant Ventures | Series A |
| Novo Holdings | Series A |
| The Export and Investment Fund of Denmark | Series A |
| SR One | Series A |
| Longview Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Presenting at the American Diabetes Association Scientific Sessions in June 2026.
- Jan 8, 2025
Dr. Joerg Moeller appointed as the new Chief Executive Officer.
Antag Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Antag Therapeutics's valuation, stock price, and market status.
